Skip to main content

Animations

MJFF Publications

3511 - 3520 of 8816 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2022
  • 2022
  • 2022
  • 2022
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    RESTRICTED
    Title: Adjunctive Therapies in Parkinson Disease—Have We Made Meaningful Progress?
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.4140
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Citius, Fortius, Altius—Understanding Which Components Drive Exercise Benefits in Parkinson Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.3744
    Citation Count: 14
  • Summary Details
    RESTRICTED
    Title: Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1601
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease—Reply
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1604
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Timing of Physical Therapy Sessions for Individuals With Parkinson Disease May Unlock Benefits
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.2649
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Six Action Steps to Address Global Disparities in Parkinson Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1783
    Citation Count: 115
  • Summary Details
    OPEN
    Title: Deep sequencing of sncRNAs reveals hallmarks and regulatory modules of the transcriptome during Parkinson’s disease progression
    Journal Name: Nature Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s43587-021-00042-6
    Citation Count: 47
  • Summary Details
    RESTRICTED
    Title: Quantitative phosphoproteomics uncovers dysregulated kinase networks in Alzheimer’s disease
    Journal Name: Nature Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s43587-021-00071-1
    Citation Count: 43
  • Summary Details
    RESTRICTED
    Title: Dysregulated miRNAs mark Parkinson’s disease progression
    Journal Name: Nature Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s43587-021-00046-2
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: RNA sequencing of whole blood reveals early alterations in immune cells and gene expression in Parkinson’s disease
    Journal Name: Nature Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s43587-021-00088-6
    Citation Count: 62
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.